| P50 | author | Hatice Hasturk | Q126812464 |
| P2093 | author name string | Kazem Behbehani | |
| | Mutsuko Ohnishi | |
| | Mohammed S Razzaque | |
| | J Max Goodson | |
| | Mor-Li Hartman | |
| | Tina Yaskell | |
| | Mary Tavares | |
| | Constantino Floros | |
| | Francisco Groppo | |
| P2860 | cites work | Sodium-phosphate cotransporter in human salivary glands: molecular evidence for the involvement of NPT2b in acinar phosphate secretion and ductal phosphate reabsorption | Q24305969 |
| | The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis | Q24625902 |
| | FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? | Q24653541 |
| | Is obesity an oral bacterial disease? | Q24653716 |
| | Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis | Q24671728 |
| | Leptin and the regulation of body weight in mammals | Q29615976 |
| | Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems | Q33485414 |
| | In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels | Q33572351 |
| | Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging | Q34072221 |
| | Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions | Q35003219 |
| | Osteo-renal regulation of systemic phosphate metabolism | Q35059741 |
| | Phosphate toxicity: new insights into an old problem | Q35059905 |
| | Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase | Q35126790 |
| | Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism | Q35151453 |
| | Expression of podoplanin and classical cadherins in salivary gland epithelial cells of klotho-deficient mice | Q35688180 |
| | FGF23 in skeletal modeling and remodeling | Q35707031 |
| | Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands | Q35943927 |
| | Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter | Q36191092 |
| | Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor | Q36217292 |
| | Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice | Q36992835 |
| | The role of Klotho in energy metabolism | Q36992839 |
| | In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis | Q37072412 |
| | Can features of phosphate toxicity appear in normophosphatemia? | Q37244863 |
| | Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model | Q37415834 |
| | Clinical consequences of mutations in sodium phosphate cotransporters | Q38003768 |
| | Adolescent bariatric surgery | Q38032513 |
| | Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice | Q38346068 |
| | Fatness, fitness, and increased cardiovascular risk in young children | Q43028042 |
| | Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. | Q46003190 |
| | The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease | Q46083189 |
| | Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects | Q46878262 |
| | The relationship between serum phosphate levels with childhood obesity and insulin resistance. | Q51374135 |
| | Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. | Q51467220 |
| | Acute stimulation of glucose metabolism in mice by leptin treatment | Q59079790 |
| | A comparison of salivary calcium, phosphate, and alkaline phosphatase in children with severe, moderate caries, and caries free in Tehran's kindergartens | Q81586474 |
| | Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan | Q81948529 |
| | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass | Q85173986 |
| P921 | main subject | obesity | Q12174 |
| | biomarker | Q864574 |
| P304 | page(s) | 138-148 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | Contributions to Nephrology | Q15755655 |
| P1476 | title | Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? | |
| P478 | volume | 180 | |